Matches 1 - 50 out of 144 1 2 3 >
Match Document Document Title
7625922 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds  
The present invention pertains to certain imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof, which, inter alia, inhibit RAF (e.g., B-RAF) activity, inhibit...
7622482 Chemical compounds  
This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
7605154 Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors  
The present invention is directed to novel thiazolopyrimidine compounds of Formula (I) or a form or composition thereof and the use thereof as inhibitors of ATP-protein kinase interactions.
7598254 Substituted 1,3-thiazolo[5,4-d]pyrimidines as xanthine oxidase inhibitors  
The invention relates to compounds of the following formula (I) or their salts: in which R 1 is a group of phenyl, naphthyl, pyridyl or the like which may have a substituent such as an alkyl...
7585867 Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one  
A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy.
7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors  
Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and...
7557112 Aromatic-ring-fused pyrimidine derivative  
There are provided novel pyrimidine derivatives which has been fused with an aromatic heterocycle selected from thiophene, thiazole and pyridine or pharmaceutically acceptable salts thereof; and a...
7498333 Enantiomers of selected fused heterocyclics and uses thereof  
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or...
7476677 Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of Tie2  
A compound of the formula(I); wherein the substituents are as defined in the text for use in the production of an anti-angiogenic effect in a warm blooded animal such as man. The compounds are...
7470693 Oxalamide derivatives as kinase inhibitors  
The invention is directed to compounds having the following Formula I: and methods of using them for the treatment of proliferative diseases.
7439246 Fused heterocyclic kinase inhibitors  
In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase...
7427616 Condensed pyridines and pyrimidines with tie2 (TEK) activity  
A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms...
7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties  
The present invention is directed to curcumin analogs exhibiting anti-tumor and anti-angiogenic properties, pharmaceutical formulations including such compounds and methods of using such compounds.
7351826 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds  
The invention provides compounds of Formula (I) that bind to GABA A receptors. In the above formula, variables are defined herein. Such compounds may be used to modulate ligand binding to GABA A ...
7321033 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof  
The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention...
7294633 Oxazolo-and furopyrimidines and their use in medicaments against tumors  
The invention relates to pharmaceutically acceptable compounds of formula I, wherein the radicals have the significances given in the description. Compounds of formula I are useful against tumor...
7262186 Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor  
The present invention relates to azolopyriniidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for...
7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor  
The present invention relates to azolopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for...
7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors  
The invention relates to compounds of the following formula (I) or their salts: in which R 1 represents OR 4 or others, in which R 4 is an alkyl group having 1-8 carbon atoms which may have...
7244727 Fused bicyclic nitrogen-containing heterocycles  
Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the...
7179915 Method for producing highly pure tris-ortho metalated organoiridium compounds  
The present invention describes a process for preparing highly pure tris-ortho-metalled organoiridium compounds and pure organometallic compounds of this type, especially compounds of the d 8 ...
7176215 Bicyclic oxopyridine and oxopyrimidine derivatives  
Compounds of formulae (1a) and (1b) are described: in which the dashed line represents an optional bond; A is a —N═ atom or a —N(R b )—, —C(R b )═ or —C(R b )(R C )— group; R a , R...
7141564 Nitrogen-containing bicyclic heterocycles for use as antibacterials  
Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man.
7115739 Triazole compounds useful as protein kinase inhibitors  
This invention describes novel triazole compounds of formula IX: wherein Z 1 is nitrogen or CR 9 and Z 2 is nitrogen or CH, provided that at least one of Z 1 and Z 2 is nitrogen; G is Ring...
7105524 Pesticidal and parasiticidal di-and trifluorosubstituted alkene compounds  
Di- and trifluorosubstituted alkene compounds of formula I wherein X is hydrogen or fluorine; Y is oxygen, NR 1 or S(O) m ; R 1 is hydrogen or C 1 –C 6 -alkyl; m is 0, 1, or 2; ...
7067657 Thiazolopyrimidine derivatives and use thereof as antagonists of the CX3 CR1 receptor  
Provided herein is a compound having the formula (Ia): wherein said compounds are useful for the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain.
7022850 Bicyclicpyrimidones and their use to treat diseases  
The present invention is directed to dihydropyrimidones having formula I or II and methods of using them to induce mitotic arrest, thereby making them useful as anti-cancer agents and other...
6969713 Piperidine and piperazine acetamide derivatives  
The invention provides piperidine and piperazine derivatives of general formula (I), processes for their preparation, pharmaceutical compositions containing them, a process for preparing the...
6958343 Thiazolopyrimidines and their use as modulators of chemokine receptor activity  
Compounds of formula (I): are described herein. The compounds can be used, for example, in the treatment of chemokine mediated diseases, including inflammatory diseases such as psoriasis and...
6949643 Thiazolopytimidines and their use as modulators of chemokine receptor activity  
The invention provides certain thiazolopyrimidine compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof: in which: A is a group of formula (a) or (b): processes and...
6930101 Thiazolopyrimidines useful as TNFα inhibitors  
The invention provides derivatives of thiazolo[4,5-dl]pyrimidine and their use as inhibitors of proinflammatory cytokines.
6841549 Condensed imidazole compounds and a therapeutic agent for diabetes mellitus  
The present invention provides a preventive or therapeutic agent for diabetes mellitus and diabetic complications, which is a new type based on an adenosine A2 receptor antagonist action. That is,...
6835726 Pyrimidine derivatives  
Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.
6828326 Pyrimidinone fused bicyclic metalloproteinase inhibitors  
The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula wherein A, B, X, Y, and R 1 are as defined in the specification, and to pharmaceutical compositions...
6790850 Thiazolo(4,5-d)pyrimidine compounds  
The invention provides certain thiazolopyrimidine compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof; processes and intermediates used in their preparation,...
6777416 Isoxazolo pyrimidinones and the use thereof  
The invention relates to novel isoxazolo pyrimidinones of general formula (I), a method for producing the same and the pharmaceutical use thereof.
6734180 NF-&kgr B inhibitor comprising an indan derivative as an active ingredient  
An inhibitor of NF-κB comprising as an active ingredient an indan derivative represented by the general formula (I) or a salt thereof.
6617330 Pyrimidin-4-enamine as fungicide  
Novel pyrimidine derivatives of formula I as well as possible isomers and mixtures of isomers thereof. The novel compounds have plant-protective properties and are suitable for protecting plants...
6589958 Isoxazolo &lsqb 4,5-d&rsqb pyrimidines as CRF antagonists  
The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula: wherein R is an aromatic or heteroaromatic ring, or pharmaceutically acceptable salt form thereof, which are useful...
6525056 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders  
Corticotropin releasing factor (CRF) antagonists of Formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress...
6410628 Photoactivatable nitrogen-containing bases based on alpha-amino ketones  
The invention relates to organic compounds having a molecular weight of less than 1000 comprising at least one structural unit of the formula (I) in which R 1 is an aromatic or heteroaromatic...
6376667 Solid phase synthesis of heterocycles  
Methods and compounds for the synthesis of heterocycles, including pyrimidine-2,4-diones, are disclosed. Also disclosed are solid supports useful for solid phase synthesis, and methods for making...
6228867 Antagonists of gonadotropin releasing hormone  
There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety...
6200957 Antagonists of gonadotropin releasing hormone  
There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety...
6165942 Heterocycle-fused pyrimidinone derivative and herbicidal composition  
A compound represented by the general formula (I) and a salt thereof: ##STR1## wherein: Rf represents a (C 1 -C 4 )haloalkyl group; X.about.Y represents NN or CHN or the like; A represents a...
6159975 Antagonists of gonadotropin releasing hormone  
There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety...
6143748 Process for synthesis of nucleoside analogues  
The present invention is concerned with a process for the preparation of antiviral 1,3-oxathiolane nucleosides comprising an intramolecular glycosylation reaction to produce exclusively the...
6133270 Isothiazolones and pharmaceutical formulations  
Isothiazolones having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R 1 and R 2 are substituent groups...
6124306 Thioalkyl alpha substituted pyrimidine compounds  
The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula I ##STR1## and pyrimidine-thioalkyl and alkylethers of Formula I, where R 4 is selected from the group...
6124298 Pyrazinedicarboxylic-acid derivatives as cell proliferation regulators  
The present invention relates to novel pyrazine compounds and their use in the regulation of haematopoiesis, in particular in the stimulation of haematopoiesis, and in the treatment of bacterial,...
Matches 1 - 50 out of 144 1 2 3 >